Industry Updates
- Shortages, Other COVID-19 Impacts to Affect Device Makers Into Next Year
- EU Expert Panels to Review High-Risk IVDs
- Australia’s TGA Sues Medtronic for Unlawful Supply of Bone Graft Kit
- FDA, ECRI Release First Reports on Safety of Materials Used in Implantable Devices
- Australia Reports Progress in Implementing Medical Device Reforms
- KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged
- Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination
- Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter
- 2023 Safety Communications
- Update: Recommendations for Certain O&M Halyard Surgical N95 Respirators, Surgical Masks, and Pediatric Face Masks: FDA Safety Communication
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
- Time to Eliminate Health Care Disparities in the Estimation of Kidney Function
- Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America
- The 2021 Reauthorization of CAPTA — Letting Public Health Lead
- Point-of-Care Ultrasonography